Obesity is characterized by excessive body fat accumulation and is a high-risk factor for
metabolic comorbidities, including type 2 diabetes, nonalcoholic fatty liver disease, and …

Obesity is a chronic disease characterized by abnormal or excessive fat accumulation that
could impact an individual's health; moreover, the World Health Organization (WHO) has …

Colchicine (COL) is known for its ability to inhibit the formation of intestinal chylomicrons and
has been utilized as a non-surgical tool to explore drug absorption via the intestinal …

The epidemic of obesity, type 2 diabetes and nonalcoholic liver disease (NAFLD) favors
drug consumption, which augments the risk of adverse events including liver injury. For …

Cycloheximide (CHX) has been used to reduce the flow of intestinal lymph and as a non-
surgical tool to study drug absorption via the intestinal lymphatics. Pharmacokinetic …

Cytochrome P450 2D (CYP2D) is important in psychopharmacology as it is engaged in the
metabolism of drugs, neurosteroids and neurotransmitters. An unbalanced maternal diet …

Background Maternal undernutrition during pregnancy disrupts both fetal growth and
development with perturbations to certain physiological processes within the maternal-fetal …

Background and Purpose Overweight or obese patients exhibit poorer platelet responses to
clopidogrel. However, the mechanisms behind this phenotype remain to be elucidated …

The increase in the prevalence of obesity has led to an elevated risk for several associated
diseases including cancer. Several studies have investigated the DNA damage in human …

Introduction Non-alcoholic fatty liver disease (NAFLD) is characterised by accumulation of
triglycerides and cholesterol within the liver and dysregulation of specific hepatic …